Publications by authors named "Todd Defor"

Claim this Profile
S
Solid Organ Malignancy After Pancreas Transplantation: A Four Decade Single-Center Experience.
Michael G Megaly, Todd DeFor, Xianghua Luo, Michael Dryden, Joseph Sushil Rao

Clin Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched Unrelated vs Haploidentical Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Dipenkumar Modi, Yosra M Aljawai, Todd E DeFor, Caitrin Bupp, Monzr M Al Malki

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Younger Age Is Associated with Favorable Outcomes in Adult Dogs with Hemangiosarcoma Receiving Adjuvant Doxorubicin Chemotherapy: Results from the PRO-DOX Study.
Antonella Borgatti, Brian D Husbands, Aaron L Sarver, Jeremy M Chacón, Todd E DeFor

Res Sq· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2B6 genetic variation in cyclophosphamide metabolism and hemorrhagic cystitis in Fanconi anemia patients undergoing allogeneic hematopoietic cell transplantation: A descriptive genetic association study.
Asmaa Ferdjallah, Susie Long, Todd E DeFor, Cody Hoffmann, John E Wagner

Medicine (Baltimore)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation.
Brian C Shaffer, Mahasweta Gooptu, Todd DeFor, Stephen R Spellman, Heather E Stefanski

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAST Regimen for GvHD Prophylaxis: A CIBMTR Propensity Score-Matched Analysis.
A Samer Al-Homsi, Todd E DeFor, Kelli Cole, Frank Cirrone, Stephanie King

Transplant Cell Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.
Brian C Shaffer, Mahasweta Gooptu, Todd E DeFor, Martin Maiers, Javier Bolaños-Meade

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of melphalan day -1 vs day -2 on outcomes after autologous stem cell transplant for multiple myeloma.
Aimee Merino, Ryan Shanley, Faridullah Rashid, Jenna Langer, Michelle Dolan, Todd DeFor

Front Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harvest Quality, Nucleated Cell Dose and Clinical Outcomes in Bone Marrow Transplantation: A Retrospective Study.
Theodros Mamo, Darin Sumstad, Todd E DeFor, Qing Cao, Margaret L MacMillan

Transplant Cell Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma.
Frank Cichocki, Bin Zhang, Cheng-Ying Wu, Emily Chiu, Abderrahman Day, Todd E Defor

Sci Transl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation.
Armin Rashidi, Eric J Huselton, Heather E Stefanski, Todd E DeFor, Ryan Shanley

Transplant Cell Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients.
Divya Bhargava, Cathleen Drilling, Todd E DeFor, Claudio G Brunstein, Bharat Thyagarajan

Bone Marrow Transplant· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High cutaneous amphiregulin expression predicts fatal acute graft-versus-host disease.
Brittney Schultz, Daniel D Miller, Todd DeFor, Bruce R Blazar, Angela Panoskaltsis-Mortari

J Cutan Pathol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of outcomes after second-line treatment for acute graft-versus-host disease.
Phuong Vo, Ted A Gooley, Paul A Carpenter, Mohamed L Sorror, Margaret L MacMillan, Todd E DeFor

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors and outcomes of flares in chronic graft-versus-host disease.
Najla El Jurdi, Grigori Okoev, Todd E DeFor, Shernan G Holtan, Brian C Betts

Bone Marrow Transplant· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of continuous versus intermittent infusion cyclosporine and impact on transplant related outcomes in allogeneic transplant recipients.
Jeff A Engle, Justin A Wasko, John Rogosheske, Todd E Defor, Armin Rashidi

J Oncol Pharm Pract· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engraftment of Double Cord Blood Transplantation after Nonmyeloablative Conditioning with Escalated Total Body Irradiation Dosing to Facilitate Engraftment in Immunocompetent Patients.
Claudio G Brunstein, Todd E DeFor, Ephraim J Fuchs, Chatchada Karanes, Joseph P McGuirk

Transplant Cell Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-Onset Acute and Chronic Graft-versus-Host Disease in Children: Clinical Features and Response to Therapy.
Takuto Takahashi, Mukta Arora, Grigori Okoev, Todd E DeFor, Daniel J Weisdorf

Transplant Cell Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type.
Sitalakshmi Subramanian, Claudia Cohn, Todd DeFor, Julie Welbig, Claudio Brunstein

Transfusion· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infusion reactions in natural killer cell immunotherapy: a retrospective review.
Tewodros Mamo, Shelly M Williams, Stephanie Kinney, Katelyn M Tessier, Todd E DeFor

Cytotherapy· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant.
Grigori Okoev, Daniel J Weisdorf, John E Wagner, Bruce R Blazar, Margaret L MacMillan, Todd DeFor

Bone Marrow Transplant· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation.
Georgios E Christakopoulos, Todd E DeFor, Stefanie Hage, John E Wagner, Michael A Linden

Transplant Cell Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group.
Najla El Jurdi, Heba Elhusseini, Joan Beckman, Todd E DeFor, Grigori Okoev

Blood Cancer J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes.
Najla El Jurdi, Ahmad Rayes, Margaret L MacMillan, Shernan G Holtan, Todd E DeFor

Blood Adv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings.
Margaret L MacMillan, Keli L Hippen, David H McKenna, Diane Kadidlo, Darin Sumstad, Todd E DeFor

Blood Adv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis